Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis Thomas W. Lee, Michael R. Kolber, Richard N. Fedorak, Sander Veldhuyzen van Zanten Journal of Crohn's and Colitis Volume 6, Issue 3, Pages 267-275 (April 2012) DOI: 10.1016/j.crohns.2011.09.010 Copyright © 2011 Terms and Conditions
Figure 1 Flow chart of literature search outcomes. Journal of Crohn's and Colitis 2012 6, 267-275DOI: (10.1016/j.crohns.2011.09.010) Copyright © 2011 Terms and Conditions
Figure 2 The mean hemoglobin improvement between IV and PO routes of iron replacement therapy. CI: confidence interval. Journal of Crohn's and Colitis 2012 6, 267-275DOI: (10.1016/j.crohns.2011.09.010) Copyright © 2011 Terms and Conditions
Figure 3 The mean difference in ferritin improvement between IV and PO routes of iron replacement therapy. CI: confidence interval. Journal of Crohn's and Colitis 2012 6, 267-275DOI: (10.1016/j.crohns.2011.09.010) Copyright © 2011 Terms and Conditions
Figure 4 Odds ratio for discontinuation of iron replacement therapy due to adverse events. CI, confidence interval; M–H, Mantel–Haenszel test. Journal of Crohn's and Colitis 2012 6, 267-275DOI: (10.1016/j.crohns.2011.09.010) Copyright © 2011 Terms and Conditions
Figure 5 The mean change in SF-36 score between IV and PO routes of iron replacement therapy. CI: confidence interval. Journal of Crohn's and Colitis 2012 6, 267-275DOI: (10.1016/j.crohns.2011.09.010) Copyright © 2011 Terms and Conditions